Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder

Condition:   Autism Spectrum Disorder (ASD) Interventions:   Drug: Bumetanide Oral Solution;   Drug: Placebo Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Recruiting

Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials